|
|
||||||||
Department of Clinical Physiology, Nuclear Medicine Department of Clinical Chemistry and Department of Medicine, Herlev University Hospital, Denmark
Correspondence: For reprints contact: Henning Kelbaek, MD, Dept. of Clinical Physiology and Nuclear Medicine, Herlev University Hospital, DK-2730 Herlev, Denmark.
ABSTRACT
A technique for in vitro labeling of human polymorphonuclear leukocytes with Tc-99m is described. Titration of stannous fluoride and stannous pyrophosphate concentrations for pretinning was performed, and optimal amounts of the stannous agents were added to polymorphonuclear leukocytes efficiently isolated from 100 ml of blood. Labeling with 1015 mCi Tc-99m resulted, after three washings of cell suspensions, in yields of 1.64.8 mCi, corresponding to 20.533.5% of added tracer. Cell-bound activity in the final cell suspensions was 92.3% ± 1.9 of the added dose. Cell function was not impaired by the labeling technique. Sterility and exclusion of bacterial endotoxins in the final cell suspensions were demonstrated. The method may prove of diagnostic value in the isolation, labeling, and reinjection of autologous leukocytes for scintigraphic imaging of acute inflammatory lesions.
This article has been cited by other articles:
![]() |
D. Hommer, P. Andreasen, D. Rio, W. Williams, U. Ruttimann, R. Momenan, A. Zametkin, R. Rawlings, and M. Linnoila Effects of m-Chlorophenylpiperazine on Regional Brain Glucose Utilization: A Positron Emission Tomographic Comparison of Alcoholic and Control Subjects J. Neurosci., April 15, 1997; 17(8): 2796 - 2806. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |